Thoroughbred Financial Services LLC Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Thoroughbred Financial Services LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 25.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 12,185 shares of the healthcare conglomerate's stock after selling 4,096 shares during the quarter. Thoroughbred Financial Services LLC's holdings in UnitedHealth Group were worth $6,164,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank acquired a new position in UnitedHealth Group in the fourth quarter valued at $6,375,744,000. Raymond James Financial Inc. purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $1,914,740,000. Amundi raised its stake in UnitedHealth Group by 97.2% during the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after acquiring an additional 2,991,470 shares during the last quarter. Proficio Capital Partners LLC grew its stake in shares of UnitedHealth Group by 76,830.4% in the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock valued at $955,388,000 after purchasing an additional 1,886,186 shares during the last quarter. Finally, Franklin Resources Inc. raised its stake in shares of UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock worth $4,514,178,000 after purchasing an additional 861,854 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on UNH shares. KeyCorp reissued an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial cut their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a report on Monday, January 6th. Oppenheimer boosted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Finally, Barclays reduced their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $629.32.

UnitedHealth Group Price Performance

NYSE:UNH traded down $15.50 during trading hours on Friday, reaching $524.94. 9,914,705 shares of the company traded hands, compared to its average volume of 4,261,985. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm's 50-day moving average is $509.24 and its 200-day moving average is $542.37. The stock has a market cap of $480.17 billion, a P/E ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the firm earned $5.83 EPS. The firm's quarterly revenue was up 6.8% on a year-over-year basis. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the company's stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.